Emmie de Wit

Last updated
Emmie de Wit
Emmie de Wit.png
NationalityDutch
Alma mater Erasmus University Rotterdam (PhD)
Spouse
(m. 2009)
Awards Golden Goose Award (2020)
Scientific career
FieldsViral pathogenesis
Institutions Rocky Mountain Laboratories

Emmie de Wit is a Dutch-American virologist. She is chief of the molecular pathogenesis unit at the Rocky Mountain Laboratories. Her research combines pathogenesis studies with detailed molecular analyses to identify molecular determinants of severe respiratory tract disease within the virus and the host.

Contents

Education

Emmie de Wit is from the Netherlands. [1] She received her Ph.D. in virology in 2006 from Erasmus University Rotterdam. Her research focused on the replication, pathogenesis and transmission of influenza A virus. [2] Her dissertation was titled Molecular determinants of influenza A virus replication and pathogenesis. [3]

Career

In 2009, de Wit moved to Heinz Feldmann's Laboratory of Virology at the Rocky Mountain Laboratories (RML) to research in the biosafety level 4 laboratory. Here, she focused on the pathogenesis of and countermeasures against Nipah virus, the Middle East Respiratory Syndrome Coronavirus and the 1918 H1N1 influenza A virus (Spanish flu). [2] In 2012, she received a Fellows Award for Research Excellence (FARE) for her research on modeling the transmission cycle of the deadly Nipah virus. [4] From 2014 to 2015, de Wit spent 4 months in a field lab in Monrovia, Liberia in charge of patient diagnostics for several Ebola Treatment Units in the area, to help contain the Ebola virus epidemic in Liberia. Currently, de Wit's research aims to combine pathogenesis studies with detailed molecular analyses to identify molecular determinants of severe respiratory tract disease within the virus and the host. She is chief of the molecular pathogenesis unit at RML. [2]

In 2020, de Wit was named as a co-recipient of a Golden Goose Award for excellence in federally funded research with Kizzmekia Corbett, Barney Graham and her spouse Vincent Munster. [5]

Personal life

While a PhD student at Erasmus University Rotterdam, de Wit met researcher Vincent Munster, whom she married in 2009. [5] Munster has a separate research lab at Rocky Mountain Laboratories [5] and is also a virologist. [6]

Related Research Articles

<span class="mw-page-title-main">Vincent Racaniello</span> American biologist

Vincent R. Racaniello is a Higgins Professor in the Department of Microbiology and Immunology at Columbia University's College of Physicians and Surgeons. He is a co-author of a textbook on virology, Principles of Virology.

Clarence James Peters, Jr is a physician, field virologist and former U.S. Army colonel. He is noted for his efforts in trying to stem epidemics of exotic infectious diseases such as the Ebola virus, Hanta virus and Rift Valley fever (RVF). He is an eminent authority on the virology, pathogenesis and epidemiology of hemorrhagic fever viruses.

<span class="mw-page-title-main">Rocky Mountain Laboratories</span>

Rocky Mountain Laboratories (RML) is part of the NIH Intramural Research Program and is located in Hamilton, Montana. Operated by the National Institute of Allergy and Infectious Diseases, RML conducts research on maximum containment pathogens such as Ebola as well as research on prions and intracellular pathogens such as Coxiella burnetii and Francisella tularensis. RML operates one of the few Biosafety level 4 laboratories in the United States, as well as Biosafety level 3 and ABSL3/4 laboratories.

<span class="mw-page-title-main">Vaccine Research Center</span>

The Vaccine Research Center (VRC), is an intramural division of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), US Department of Health and Human Services (HHS). The mission of the VRC is to discover and develop both vaccines and antibody-based products that target infectious diseases.

<span class="mw-page-title-main">Wendy Barclay</span> British virologist

Wendy Sue Fox is a British virologist. She is currently head of Department of Infectious Disease and chair in Influenza Virology at Imperial College London. She leads a team of scientists studying the influenza virus and its physiology and morphology to discover novel vaccines. In particular, they are trying to understand more about influenza virus mutations, and how they can allow scientists to create new vaccines against possible flu pandemics.

Karl M Johnson was an American virologist, known for discovering Machupo virus, Hantaan virus, and Ebola virus. He has held key positions in the American Society of Tropical Medicine and Hygiene.

<span class="mw-page-title-main">Hélio Gelli Pereira</span> Brazilian-British virologist

Hélio Gelli Pereira was a Brazilian-British virologist specialising in adenoviruses. Pereira was a co-recipient of the 1988 UNESCO Carlos J. Finlay Prize for Microbiology and was known for his work on the book, Viruses of Vertebrates. He contributed to several areas of virology in research and international public service.

<span class="mw-page-title-main">Robert A. Lamb</span> British-American virologist (1950–2023)

Robert A. Lamb was a British-American virologist. He was the Kenneth F. Burgess Professor at Northwestern University and since 1991, an investigator of the Howard Hughes Medical Institute. From 1990 to 2016, he was the John Evans Professor of Molecular and Cellular Biology at Northwestern University.

Anna Marie (Ann) Skalka is an American virologist, molecular biologist and geneticist who is professor emeritus and senior advisor to the president at the Fox Chase Cancer Center. She is a co-author of a textbook on virology, Principles of Virology.

<span class="mw-page-title-main">Sean Whelan (scientist)</span> British-American virologist

Sean Whelan is a British-American virologist. He is known for identifying the cellular protein used as a receptor by Ebola virus, for defining the entry pathway that rabies virus uses to enter neurons, and for identifying the ribosome as a possible target for antiviral drugs. In July 2019, he was announced as the new Chair of the Department of Molecular Microbiology at Washington University School of Medicine in St Louis, Missouri. In February 2020, Whelan was recognized as the LGBTQ+ Scientist of the Year 2020 by the National Organization of Gay and Lesbian Scientists and Technical Professionals.

<span class="mw-page-title-main">Brian R. Murphy</span> American virologist

Brian R. Murphy is an American virologist and former co-chief of the Laboratory of Infectious Diseases at the National Institute of Allergy and Infectious Disease.

<span class="mw-page-title-main">Sonja M. Best</span> Australian-American virologist

Sonja Marie Best is an Australian-American virologist. She is chief of the innate immunity and pathogenesis section at the Rocky Mountain Laboratories. Best researches interactions between pathogenic viruses and the host immune response using flavivirus as a model.

<span class="mw-page-title-main">Andrea Marzi</span> German-American virologist

Andrea Marzi is a German-American virologist. She is chief of the immunobiology and molecular virology unit at the Rocky Mountain Laboratories. Marzi investigates the pathogenesis of filoviruses and vaccine development. She received the Loeffler-Frosch medal in recognition of her research.

<span class="mw-page-title-main">Angela Rasmussen</span> American virologist and researcher

Angela Lynn Rasmussen is an American virologist at the Vaccine and Infectious Disease Organization at the University of Saskatchewan in Canada.

Ya-Chi Ho is a Taiwanese infectious disease researcher and Associate Professor of Microbial Pathogenesis and Medicine at Yale University. Her research centers on the interaction between HIV and the host's immune system with the ultimate goal of curing HIV/AIDS.

<span class="mw-page-title-main">Jacqueline Katz</span> Australian-American microbiologist

Jacqueline Marion Katz is an Australian-American microbiologist serving as the deputy director of the influenza division at the National Center for Immunization and Respiratory Diseases.

Xiang-Jin Meng, also known as X.J. Meng, is a Chinese-born American virologist. He is a university distinguished professor at Virginia Tech. He studies emerging, re-emerging and zoonotic viruses of veterinary and human public health significance. He was elected a member of the National Academy of Sciences in 2016, a Fellow of the National Academy of Inventors in 2014, a Fellow of the American Academy of Microbiology in 2012, and a Fellow of the American Association for the Advancement of Science.

<span class="mw-page-title-main">Heinz Feldmann</span> German-American virologist

Heinz (Heinrich) Ulrich Feldmann is a German-American virologist who currently serves as the chief of the laboratory of virology at Rocky Mountain Laboratories, NIAID and heads the Disease Modelling and Transmission section. His research focuses on highly pathogenic viruses that require strict biocontainment, including those that cause viral hemorrhagic fever such as Ebola and Lassa. He has been responsible for the development of timely viral countermeasures including the rVSV-ZEBOV vaccine (Ervebro), development of vaccines and drugs against SARS-CoV-2, and epidemiology of SARS-CoV.

Gain-of-function research is medical research that genetically alters an organism in a way that may enhance the biological functions of gene products. This may include an altered pathogenesis, transmissibility, or host range, i.e., the types of hosts that a microorganism can infect. This research is intended to reveal targets to better predict emerging infectious diseases and to develop vaccines and therapeutics. For example, influenza B can infect only humans and harbor seals. Introducing a mutation that would allow influenza B to infect rabbits in a controlled laboratory situation would be considered a gain-of-function experiment, as the virus did not previously have that function. That type of experiment could then help reveal which parts of the virus's genome correspond to the species that it can infect, enabling the creation of antiviral medicines which block this function.

Anne Moscona is an American virologist and pediatrician. She is best known for identifying cell entry mechanisms for enveloped respiratory viruses, elucidating general infection mechanisms that apply to parainfluenza virus, Nipah virus, measles virus, and other viruses, and for applying this knowledge to identify antiviral strategies to prevent infection by viruses including SARS-CoV-2. She is frequently consulted as a medical expert during viral outbreaks, including epidemic and pandemic influenza. Since 2016, she has served as the Sherie L. Morrison Professor Microbiology & Immunology, Professor of Pediatrics, and Professor of Physiology & Cellular Biophysics at Columbia University Medical Center in New York City, where she directs the Center for Host Pathogen Interaction. In 2022, Moscona was elected as president of the American Society for Virology, the nation's leading virology research organization, and will lead the organization starting in July 2023. For the last two years she has served the American Society for Virology as Councilor for Medical Virology.

References

  1. Bichell, Rae Ellen (2016-12-04). "What It's Like To Handle The Nastiest Pathogens As Your Day Job". NPR. Retrieved 2020-03-29.
  2. 1 2 3 "Emmie de Wit, Ph.D. | NIH: National Institute of Allergy and Infectious Diseases". www.niaid.nih.gov. Retrieved 2020-03-29.
  3. Wit, Emmie de (2006). Molecular determinants of influenza A virus replication and pathogenesis (Thesis). OCLC   150315522.
  4. Mott, Meghan; NIAAA (2013-05-13). "The Perils of Nipah Virus and Ischemic Stroke". NIH Intramural Research Program. Retrieved 2020-03-29.
  5. 1 2 3 Heath, Erin. "2020: A Spike in Momentum". The Golden Goose Award. Retrieved 22 March 2023.
  6. "Vincent Munster, Ph.D." Laboratory of Virology. National Institute of Allergy and Infectious Diseases. 20 January 2023. Retrieved 22 March 2023.
PD-icon.svg This article incorporates public domain material from websites or documents of the National Institutes of Health.